Biosergen
0.572
SEK
+14.4 %
BIOSGN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 following
+14.4%
-5.3%
-9.21%
+85.71%
+9.94%
-5.15%
-82.38%
-
-84.53%
Biosergen is a biotechnology company. The company specializes in the research and development of various pharmaceuticals. The product portfolio includes, for example, the company's product BSG005, a fungicidal pharmaceutical in the clinical phase. In addition to the main business, service and associated ancillary services are also offered. The company operates in Norway. Biosergen was founded in 2004 and is headquartered in Solna.
Read moreMarket cap
134.32M SEK
Turnover
164.01K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
31/3
2025
Annual report '24
ShowingAll content types
Biosergen AB: Biosergen samtycker till accelererad dosökning i den pågående andra kohorten i den kliniska prövningen
Biosergen AB: Biosergen resolves on a compensation issue to underwriters in connection with the completed exercise period for warrants of series TO3
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools